Document is current
Any future updates will be listed below
-
Authors
Gao, Jingjing
Gunasekar, Swetharajan
Xia, Ziting https://orcid.org/0009-0003-6666-7430
Shalin, Kiruba
Jiang, Christopher
Chen, Hao
Lee, Dongtak https://orcid.org/0000-0001-8716-1736
Lee, Sohyung
Pisal, Nishkal D.
Luo, James N. https://orcid.org/0000-0001-9782-2323
Griciuc, Ana
Karp, Jeffrey M. https://orcid.org/0000-0002-4752-7374
Tanzi, Rudolph https://orcid.org/0000-0002-7032-1454
Joshi, Nitin https://orcid.org/0000-0001-8138-7611
- License Information
-
More Information
Article History
Accepted: 23 May 2024
First Online: 19 June 2024
Competing interests
: A.G. and R.T. have issued patents on all forms of gene therapy and immunotherapy for neuroinflammation using CD33 as a target. N.J. and J.M.K. have one pending patent on nanoparticles for gene delivery in the brain.
